Cross-sectional comparison of point-ofcare with laboratory HbA1c in detecting diabetes in real-world remote Aboriginal settings

BMJ Open

Volumn 5, Issue 3, 2015, Pages

  Marley, Julia V ^a,b   Oh, May S ^b   Hadgraft, Nyssa ^b   Singleton, Sally ^b   Isaacs, Kim ^b   Atkinson, David ^a,b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b Kimberley Aboriginal Medical Services Council   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ACCREDITATION; ADOLESCENT; ADULT; AGED; ARTICLE; AUSTRALIA; CAPILLARY BLOOD; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HEALTH CARE PRACTICE; HUMAN; INDIGENOUS PEOPLE; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POINT OF CARE TESTING; PREDICTIVE VALUE; PRIMARY HEALTH CARE; SCREENING TEST; SENSITIVITY AND SPECIFICITY; TRAINING; VENOUS BLOOD; DIABETES MELLITUS, TYPE 2; GLUCOSE BLOOD LEVEL; METABOLISM; OCEANIC ANCESTRY GROUP; ORGANIZATION AND MANAGEMENT; POINT OF CARE SYSTEM; PUBLIC HEALTH; REPRODUCIBILITY; RURAL HEALTH CARE; STATISTICS AND NUMERICAL DATA; WESTERN AUSTRALIA;

BLOOD GLUCOSE; CLINICAL LABORATORY TECHNIQUES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; NATIONAL HEALTH PROGRAMS; OCEANIC ANCESTRY GROUP; POINT-OF-CARE SYSTEMS; REPRODUCIBILITY OF RESULTS; RURAL HEALTH SERVICES; WESTERN AUSTRALIA;

EID: 84926429967     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2014-006277     Document Type: Article

References (30)

1. Marley JV, Nelson C, O'Donnell V, et al. Quality indicators of diabetes care: an example of remote-area aboriginal primary health care over 10 years. Med J Aust 2012;197:404-8.
2. World Health Organization. Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus. Abbreviated Report of a WHO Consultation. Geneva: World Health Organization, 2011.
3. American Diabetes Association. Standards of medical care in diabetes-2010. Diabetes Care 2010;33(Suppl 1):S11-61.
4. The International Expert Committee. International expert committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 2009;32:1327-34.
5. Colagiuri S, Davies D, Girgis S, et al. National evidence based guideline for case detection and diagnosis of type 2 diabetes. Canberra: Diabetes Australia and the NHMRC, 2009.
6. World Health Organization, International Diabetes Federation. Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia. Geneva: WHO and IDF, 2006.
7. Department of Health, Australian Government. MBS Online: The November 2014 Medicare Benefits Schedule. Secondary MBS Online: The November 2014 Medicare Benefits Schedule 2014. http://www.health.gov.au/internet/mbsonline/publishing.nsf/Content/ Downloads-2014-11
8. Martin DD, Shephard MD, Freeman H, et al. Point-of-care testing of HbA1c and blood glucose in a remote Aboriginal Australian community. Med J Aust 2005;182:524-7.
9. Shemesh T, Rowley KG, Shephard M, et al. Agreement between laboratory results and on-site pathology testing using Bayer DCA2000+ and Cholestech LDX point-of-care methods in remote Australian Aboriginal communities. Clin Chim Acta 2006;367:69-76.
10. Shephard MD. Cultural and clinical effectiveness of the 'QAAMS' point-of-care testing model for diabetes management in Australian Aboriginal Medical Services. Clin Biochem Rev 2006;27:161-70.
11. Shemesh T, Piers LS, O'Dea K. Use of the Bayer DCA 2000+ for the measurement of glycated haemoglobin in a remote Australian Aboriginal community. Ann Clin Biochem 2003;40(Pt 5):566-8.
12. Shephard MD. Australian Government's Department of Health and Ageing. Quality assurance for Aboriginal Medical Services. Secondary quality assurance for Aboriginal Medical Services. 2013. http://www.qaams.org.au/
13. Adelaide Health Technology Assessment. Final decision analytic protocol (DAP) to guide the assessment of HbA1c testing for the diagnosis of diabetes mellitus. 2013.
14. Marley JV, Davis S, Coleman K, et al. Point-of-care testing of capillary glucose in the exclusion and diagnosis of diabetes in remote Australia. Med J Aust 2007;186:500-3.
15. Kimberley Aboriginal Medical Services Council (KAMSC) and WA Country Health Service Kimberley. Type 2 diabetes (15/07/2009)- Kimberley chronic disease protocols. 2009.
16. Laycock A, Walker D, Harrison N, et al. Chapter 5: using research for change. Researching indigenous health: a practical guide for researchers. Melbourne: The Lowitja Institute, 2011:127.
17. Carson AP, Reynolds K, Fonseca VA, et al. Comparison of A1C and fasting glucose criteria to diagnose diabetes among U.S. adults. Diabetes Care 2010;33:95-7.
18. Lu ZX, Walker KZ, O'Dea K, et al. A1C for screening and diagnosis of type 2 diabetes in routine clinical practice. Diabetes Care 2010;33:817-19.
19. Mohan V, Vijayachandrika V, Gokulakrishnan K, et al. HbA1c cut points to define various glucose intolerance groups in Asian Indians. Diabetes Care 2010;33:515-19.
20. Shibata K, Suzuki S, Sato J, et al. Diagnostic accuracy of glycohemoglobin A1c (HbA1c) for postprandial hyperglycemia was equivalent to that of fasting blood glucose. J Clin Epidemiol 2005;58:1052-7.
21. Bachmann LM, Puhan MA, ter Riet G, et al. Sample sizes of studies on diagnostic accuracy: literature survey. BMJ 2006;332:1127-9.
22. Buderer NM. Statistical methodology: I. Incorporating the prevalence of disease into the sample size calculation for sensitivity and specificity. Acad Emerg Med 1996;3:895-900.
23. Lin LI. A concordance correlation coefficient to evaluate reproducibility. Biometrics 1989;45:255-68.
24. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1:307-10.
25. d'Emden MC, Shaw JE, Colman PG, et al. The role of HbA1c in the diagnosis of diabetes mellitus in Australia. Med J Aust 2012;197:220-1.
26. Zhang X, Gregg EW, Williamson DF, et al. A1C level and future risk of diabetes: a systematic review. Diabetes Care 2010;33:1665-73.
27. Selvin E, Ning Y, Steffes MW, et al. Glycated hemoglobin and the risk of kidney disease and retinopathy in adults with and without diabetes. Diabetes 2011;60:298-305.
28. Ackermann RT, Cheng YJ, Williamson DF, et al. Identifying adults at high risk for diabetes and cardiovascular disease using hemoglobin A1c National Health and Nutrition Examination Survey 2005-2006. Am J Prev Med 2011;40:11-17.
29. American Diabetes Association. Standards of medical care in diabetes-2014. Diabetes Care 2014;37(Suppl 1):S14-80.
30. Department of Health, Australian Government. MSAC Current Proposals. 1267-HBA1c test for the diagnosis of diabetes mellitus. Secondary MSAC Current Proposals. 1267-HBA1c test for the diagnosis of diabetes mellitus. 2014. http://www.msac.gov.au/ internet/msac/publishing.nsf/Content/1267